<html>
<head>PUBMED IDs for RN5S</head>
<body bgcolor='#C5F0F2'><h1>RN5S</h1><a href='https://pubmed.ncbi.nlm.nih.gov/975925/'>The location of RN5S genes on the chromosomes of primates.</a> January 1  1976<br><a href='https://pubmed.ncbi.nlm.nih.gov/975925/'>The location of RN5S genes on the chromosomes of primates.</a> January 1  1976<br><a href='https://pubmed.ncbi.nlm.nih.gov/975925/'>The location of RN5S genes on the chromosomes of primates.</a> January 1  1976<br><a href='https://pubmed.ncbi.nlm.nih.gov/975925/'>The location of RN5S genes on the chromosomes of primates.</a> January 1  1976<br><a href='https://pubmed.ncbi.nlm.nih.gov/9557709/'>A tandem array of minimal U1 small nuclear RNA genes is sufficient to generate a new adenovirus type 12-inducible chromosome fragile site.</a> April 29  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9557707/'>Adenovirus type 12-induced fragility of the human RNU2 locus requires p53 function.</a> April 29  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9499413/'>Metaphase fragility of the human RNU1 and RNU2 loci is induced by actinomycin D through a p53-dependent pathway.</a> May 16  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9927570/'>Coexpression of the adenovirus 12 E1B 55 kDa oncoprotein and cellular tumor suppressor p53 is sufficient to induce metaphase fragility of the human RNU2 locus.</a> February 3  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10882116/'>Activation of p53 or loss of the Cockayne syndrome group B repair protein causes metaphase fragility of human U1, U2, and 5S genes.</a> July 6  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516060/'>Viral induction of site-specific chromosome damage.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516056/'>The Journal of Gene Medicine 2002 Young Investigator Award. Japan Society of Gene Therapy.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516054/'>French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516053/'>Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516052/'>Optimisation of dendrimer-mediated gene transfer by anionic oligomers.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516051/'>Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516050/'>Uptake of plasmid/glycosylated polymer complexes and gene transfer efficiency in differentiated airway epithelial cells.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516049/'>Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516048/'>Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12516047/'>Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/20413673/'>Defining the RNA polymerase III transcriptome: Genome-wide localization of the RNA polymerase III transcription machinery in human cells.</a> September 14  2010<br></body></html>
